(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -25.66%-1.24M | 60.19%-649.08K | -5.84%-3.55M | 83.83%-165.54K | 7.32%-770.84K | -18.41%-983.83K | -143.91%-1.63M | -3.22%-3.35M | -85.37%-1.02M | 7.80%-831.7K |
Net income from continuing operations | 24.67%-1.66M | 41.28%-1.2M | -48.32%-8.45M | -31.42%-2.32M | 11.67%-1.89M | -117.77%-2.2M | -161.44%-2.04M | 31.05%-5.7M | 57.66%-1.77M | -197.17%-2.14M |
Operating gains losses | -692.79%-9.13K | 796.35%28.27K | -96.80%35.01K | 106.82%12.87K | -97.97%24.65K | -96.60%1.54K | -115.33%-4.06K | 3,029.39%1.1M | -405.35%-188.9K | 22,795.20%1.21M |
Depreciation and amortization | 10.16%4.23K | -7.37%4.29K | 167.13%17.03K | 20.93%4.25K | 129.05%4.31K | 686.48%3.84K | 841.06%4.63K | 187.64%6.37K | 395.20%3.51K | 301.49%1.88K |
Remuneration paid in stock | 2.40%869.77K | -23.41%585.52K | 13,727.88%3.65M | 1,300.99%1.06M | 748.85%974.7K | --849.39K | --764.49K | -99.48%26.4K | -102.89%-88.43K | 319.68%114.83K |
Other non cashItems | -65.65%1.06K | -65.38%1.49K | -51.82%235.64K | 1,963.13%113.08K | 4.35%115.19K | -98.21%3.07K | -97.86%4.3K | -29.58%489.08K | -96.78%5.48K | -37.41%110.39K |
Change In working capital | -222.33%-442.38K | 79.87%-73.19K | 32.60%963.24K | -4.72%962.44K | 102.22%2.86K | 1,077.17%361.61K | -208.97%-363.67K | 200.02%726.45K | 140.28%1.01M | 58.53%-128.96K |
-Change in receivables | -615.06%-166.66K | -1,221.30%-55.84K | 96.08%-2.18K | 69.08%-12.66K | -177.25%-17.65K | 309.20%32.36K | -158.42%-4.23K | -1,789.83%-55.54K | -585.64%-40.94K | 64.89%-6.37K |
-Change in prepaid assets | -67.41%60.68K | 44.74%-41.36K | 187.62%218.51K | 74.55%78.92K | 112.26%28.25K | 1,108.34%186.18K | 5.99%-74.84K | -1,015.62%-249.38K | -88.44%45.21K | 41.26%-230.39K |
-Change in payables and accrued expense | -56.49%62.25K | 108.43%24K | -27.58%746.91K | -10.90%896.18K | -107.18%-7.74K | 487.24%143.08K | -527.85%-284.6K | 247.13%1.03M | 4,695.00%1.01M | 8.44%107.79K |
-Change in other working capital | ---398.65K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -25.66%-1.24M | 60.19%-649.08K | -5.84%-3.55M | 83.83%-165.54K | 7.32%-770.84K | -18.41%-983.83K | -143.91%-1.63M | -3.22%-3.35M | -85.37%-1.02M | 7.80%-831.7K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 221.07%4.66M | 64.36%-1.41M | -10.42%-15.03M | 85.40%-215.51K | 19.46%-7.01M | -67.42%-3.85M | -248.67%-3.96M | -5.92%-13.61M | 66.83%-1.48M | -48.01%-8.7M |
Net PPE purchase and sale | --0 | 15.86%-5.76K | 74.97%-169.64K | -169.86%-72.64K | 99.42%-3.22K | 26.59%-86.94K | 93.88%-6.84K | -126.34%-677.71K | -98.72%103.98K | 90.62%-551.4K |
Net intangibles purchas and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---110.04K | ---- | ---- |
Net other investing changes | 223.87%4.66M | 64.44%-1.41M | -15.88%-14.86M | 90.28%-142.86K | 14.05%-7.01M | -72.53%-3.76M | -286.10%-3.95M | -2.17%-12.82M | ---1.47M | ---8.15M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 221.07%4.66M | 64.36%-1.41M | -10.42%-15.03M | 85.40%-215.5K | 19.46%-7.01M | -67.42%-3.85M | -248.67%-3.96M | -5.92%-13.61M | 66.83%-1.48M | -48.01%-8.7M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -99.96%2.56K | -39.86%3.78M | 79.53%19.89M | -114.39%-260.98K | -10.03%7.03M | 617.03%6.84M | 1,163.24%6.28M | -50.77%11.08M | 54.02%1.81M | -1.24%7.81M |
Net issuance payments of debt | 63.42%-15.7K | 64.82%-15.7K | 3,233.90%4.81M | -23.76%-55.23K | 11,192.83%4.95M | -11.93%-42.93K | -72.97%-44.63K | -42.00%-153.4K | 26.70%-44.63K | -12.48%-44.63K |
Net common stock issuance | --0 | --0 | 30.09%15.1M | -109.94%-189.5K | -74.59%2.08M | 593.64%6.88M | 1,109.48%6.33M | -51.68%11.61M | 53.53%1.91M | -5.52%8.19M |
Proceeds from stock option exercised by employees | --43.89K | --3.79M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other financing activities | ---25.62K | ---- | 95.67%-16.26K | ---- | ---- | ---- | ---- | 73.35%-375.26K | -1,803.70%-46.79K | 53.97%-328.47K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -99.96%2.56K | -39.86%3.78M | 79.53%19.89M | -114.39%-260.98K | -10.03%7.03M | 617.03%6.84M | 1,163.24%6.28M | -50.77%11.08M | 54.02%1.81M | -1.24%7.81M |
Net cash flow | ||||||||||
Beginning cash position | 195.66%3.53M | 263.63%1.82M | -92.13%501.7K | 106.79%2.46M | 12.86%3.22M | -76.34%1.19M | -92.13%501.7K | 43,613.49%6.38M | -88.30%1.19M | -67.58%2.85M |
Current changes in cash | 70.32%3.42M | 147.65%1.72M | 122.27%1.31M | 6.32%-642.02K | 56.40%-750.46K | 192.43%2.01M | 153.12%693.92K | -191.90%-5.89M | 82.08%-685.31K | -252.30%-1.72M |
Effect of exchange rate changes | -105.47%-712 | -534.27%-14.66K | -10.81%11.6K | 549.61%8.07K | -111.79%-7.16K | 163.78%13.01K | 90.96%-2.31K | 129.22%13K | -104.98%-1.79K | -75.04%60.75K |
End cash Position | 116.12%6.95M | 195.66%3.53M | 263.63%1.82M | 263.63%1.82M | 106.79%2.46M | 12.86%3.22M | -76.34%1.19M | -92.13%501.7K | -92.13%501.7K | -88.30%1.19M |
Free cash from | -15.46%-1.24M | 60.00%-654.83K | 10.19%-3.72M | 76.87%-238.18K | 44.03%-774.06K | -12.79%-1.07M | -109.82%-1.64M | -16.70%-4.14M | -113.64%-1.03M | 79.61%-1.38M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.